Orphan Drug Designation Granted By FDA For Major Medical Company

Unicycive Therapeutics' UNI-494 Granted Orphan Drug Designation by FDA: A Leap Forward for Kidney Transplant Patients.

All information provided in this article is accurate, factual, and up-to-date as of the time of writing.

In a landmark development within the medical field, Unicycive Therapeutics (NASDAQ:UNCY) recently announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its drug candidate, UNI-494. This groundbreaking compou…